Clinical trials
Not yet recruiting Phase 1 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Gynecologic Oncology Group | 2 |
| Aromics Therapeutics | 1 |
| Base Therapeutics (Shanghai) Co., Ltd. | 1 |
| Chong Kun Dang Pharmaceutical | 1 |
| Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 1 |
| Lumina Pharmaceuticals Inc | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Outpace Bio, Inc. | 1 |
| Peking University | 1 |
| Peking University Cancer Hospital & Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 18 |
| Endometrial Neoplasms | 5 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Fallopian Tube Neoplasms | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.